Effects of propafenone and 5‐hydroxy‐propafenone on hKv1.5 channels
- 1 November 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 125 (5) , 969-978
- https://doi.org/10.1038/sj.bjp.0702129
Abstract
The goal of this study was to analyse the effects of propafenone and its major metabolite, 5‐hydroxy‐propafenone, on a human cardiac K+ channel (hKv1.5) stably expressed in Ltk− cells and using the whole‐cell configuration of the patch‐clamp technique. Propafenone and 5‐hydroxy‐propafenone inhibited in a concentration‐dependent manner the hKv1.5 current with KD values of 4.4±0.3 μM and 9.2±1.6 μM, respectively. Block induced by both drugs was voltage‐dependent consistent with a value of electrical distance (referenced to the cytoplasmic side) of 0.17±0.55 (n=10) and 0.16±0.81 (n=16). The apparent association (k) and dissociation (l) rate constants for propafenone were (8.9±0.9)×106 M−1 s−1 and 39.5±4.2 s−1, respectively. For 5‐hydroxy‐propafenone these values averaged (2.3±0.3)×106 M−1 s−1 and 21.4±3.1 s−1, respectively. Both drugs reduced the tail current amplitude recorded at −40 mV after 250 ms depolarizing pulses to +60 mV, and slowed the deactivation time course resulting in a ‘crossover’ phenomenon when the tail currents recorded under control conditions and in the presence of each drug were superimposed. Both compounds induced a small but statistically significant use‐dependent block when trains of depolarizations at frequencies between 0.5 and 3 Hz were applied. These results indicate that propafenone and its metabolite block hKv1.5 channels in a concentration‐, voltage‐, time‐ and use‐dependent manner and the concentrations needed to observe these effects are in the therapeutical range. British Journal of Pharmacology (1998) 125, 969–978; doi:10.1038/sj.bjp.0702129Keywords
This publication has 49 references indexed in Scilit:
- Guidelines for the Use of Propafenone in Treating Supraventricular ArrhythmiasDrugs, 1995
- Current status of class III antiarrhythmic drug therapyThe American Journal of Cardiology, 1993
- PropafenoneDrugs, 1993
- Acute pharmacologic conversion of atrial fibrillation and flutter: The role of flecainide, propafenone, and verapamilThe American Journal of Cardiology, 1992
- Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgeryAmerican Heart Journal, 1992
- The Role of Genetically Determined Polymorphic Drug Metabolism in the Beta-Blockade Produced by PropafenoneNew England Journal of Medicine, 1990
- PropafenoneNew England Journal of Medicine, 1990
- Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgeryAmerican Heart Journal, 1989
- Therapeutic efficacy and safety of oral propafenone for atrial fibrillationThe American Journal of Cardiology, 1989
- PropafenoneDrugs, 1987